mdck cell culture–derived influenza vaccine (cciv) (Novartis)
90
Structured Review
Novartis
mdck cell culture–derived influenza vaccine (cciv)
Mdck Cell Culture–Derived Influenza Vaccine (Cciv), supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cciv/trivalent+mdck+cell+culture+derived+influenza+vaccine+optaflu/pm29642288-148-11-15
Average 90 stars, based on 1 article reviews
Mdck Cell Culture–Derived Influenza Vaccine (Cciv), supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cciv/trivalent+mdck+cell+culture+derived+influenza+vaccine+optaflu/pm29642288-148-11-15
Average 90 stars, based on 1 article reviews
mdck cell culture–derived influenza vaccine (cciv) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Vaccines:Article Title: Vaccines for preventing influenza in healthy adults Article Snippet: Both CCIV and TIV (Novartis Vaccines and Diagnostics) contained 15 μg of haemagglutinin per 0.5 mL dose of each of the following virus strains: A/Solomon Islands/3/2006 (H1N1)–like A/Wisconsin/67/2005 (H3N2)–like B/Malaysia/2506/2004–like Preparations were administered in the deltoid muscle of the non‐dominant arm. .. Both Article Title: Vaccines for preventing influenza in healthy adults Article Snippet: .. Both Article Title: Vaccines for preventing influenza in healthy adults Article Snippet: Participants , Participants were recruited at 56 centres in the USA, Finland, and Poland. Major exclusion criteria: health condition for which inactivated vaccine is recommended, employment prone to influenza transmission, influenza vaccination or laboratory‐confirmed influenza within 6 months of enrolment, history of Guillain‐Barré syndrome, a temperature of 37.8 °C and/or acute illness within 3 days of enrolment, and pregnancy or breastfeeding. A total of 11,404 participants were randomised: 11,382 were vaccinated and 10,844 (95%) completed the study. , . .. Interventions , Individuals aged 18 to 49 years were randomised equally, with use of an interactive voice response system, to receive a single dose of Article Title: Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. Article Snippet: .. Article Title: A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine. Article Snippet: Conventional influenza vaccine production methods have limitations due to their reliance on chicken eggs.. We evaluated whether a mammalian cell-culture system could reliably produce an influenza vaccine with favourable tolerability and immunogenicity profiles.. Adult subjects (n = 1200; 18–60 years of age) were randomized (2:2:2:1) to receive either one of three lots of a cell-culture-derived influenza vaccine (CCIV) or an egg-based trivalent inactivated influenza vaccine (TIV). Article Title: Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. Article Snippet: In 2007, by guest on February 25, 2015 http://cid.oxfordjournals.org/ D ow nloaded from 998 • CID 2010:51 (1 November) • Frey et al the European Medicines Agency approved an MDCK cell culture–derived influenza vaccine (CCIV) (Optaflu; Novartis Vaccines) [10, 11]. .. Approximately 4000 doses of this Virus:Article Title: Vaccines for preventing influenza in healthy adults Article Snippet: Both CCIV and TIV (Novartis Vaccines and Diagnostics) contained 15 μg of haemagglutinin per 0.5 mL dose of each of the following virus strains: A/Solomon Islands/3/2006 (H1N1)–like A/Wisconsin/67/2005 (H3N2)–like B/Malaysia/2506/2004–like Preparations were administered in the deltoid muscle of the non‐dominant arm. .. Both Article Title: Vaccines for preventing influenza in healthy adults Article Snippet: .. Both Article Title: Vaccines for preventing influenza in healthy adults Article Snippet: Participants , Participants were recruited at 56 centres in the USA, Finland, and Poland. Major exclusion criteria: health condition for which inactivated vaccine is recommended, employment prone to influenza transmission, influenza vaccination or laboratory‐confirmed influenza within 6 months of enrolment, history of Guillain‐Barré syndrome, a temperature of 37.8 °C and/or acute illness within 3 days of enrolment, and pregnancy or breastfeeding. A total of 11,404 participants were randomised: 11,382 were vaccinated and 10,844 (95%) completed the study. , . .. Interventions , Individuals aged 18 to 49 years were randomised equally, with use of an interactive voice response system, to receive a single dose of Article Title: Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. Article Snippet: .. Northern Blot:Article Title: Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. Article Snippet: .. Immunopeptidomics:Article Title: Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. Article Snippet: In 2007, by guest on February 25, 2015 http://cid.oxfordjournals.org/ D ow nloaded from 998 • CID 2010:51 (1 November) • Frey et al the European Medicines Agency approved an MDCK cell culture–derived influenza vaccine (CCIV) (Optaflu; Novartis Vaccines) [10, 11]. .. Approximately 4000 doses of this |